GPT and metabolic dysfunction-associated steatotic liver disease: The American Diabetes Association (ADA) recently updated its screening guidelines on June 24th, 2023, and now advises universal screening for NAFLD in individuals with T2D and prediabetes using the calculated Fibrosis 4 (FIB-4) Index, which is derived from age, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and platelet count [4].